Clinical Trial Update: Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating antibody response to MenB vaccination in babies born prematurely; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease
• Prematurity
• Vaccination-related or Meningococcal Disease Prevention

Snippet

Sponsor: St George's, University of London | Conditions: Prematurity, Vaccination | Phase 4 | Status: COMPLETED